Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 05-07-2018 |
Asset Class: Equity |
Benchmark: S&P BSE Healthcare TRI |
Expense Ratio: 2.11% As on (31-12-2022) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 2,513.92 Cr As on (31-12-2022) |
Turn over: 54% | Exit Load: 1% for redemption within 15 days |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Standard Deviation | 21.87 |
Sharpe Ratio | 0.88 |
Alpha | 2.5 |
Beta | 0.96 |
Yield to Maturity | - |
Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
24.0%
Others
5.14%
Large Cap
46.89%
Mid Cap
23.97%
There are no scheme documents available
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund